| Carrie B Dennis, CNM | |
|
5201 Harry Hines Blvd, Wish Tubal Clinic, Dallas, TX 75235-7708 | |
| (214) 590-5306 | |
| (214) 590-2798 |
| Full Name | Carrie B Dennis |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 5201 Harry Hines Blvd, Dallas, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750447132 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 639267 (Texas) | Primary |
| Entity Name | Dallas County Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831198506 PECOS PAC ID: 8325934813 Enrollment ID: O20040315000583 |
News Archive
NicOx S.A. has announced the results of a dose-ranging phase 2 study conducted with PF‑03187207 in Japanese patients with glaucoma by its partner Pfizer Inc. PF-03187207 is a nitric oxide-donating prostaglandin analog. The study was designed to compare the safety and efficacy of several doses of PF-03187207 to Xalatan (latanoprost) and enrolled 112 Japanese patients with primary open-angle glaucoma or ocular hypertension.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD) announced today that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee recommended approval of rivaroxaban, a novel, once-daily, oral anticoagulant, for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Young women who took iron supplementation for 16 weeks significantly improved their attention, short-term and long-term memory, and their performance on cognitive tasks, even though many were not considered to be anemic when the study began, according to researchers at Pennsylvania State University.
Research led by Johns Hopkins Children's Center scientists has figured out why a respiratory syncytial virus vaccine used in 1966 to inoculate children against the infection instead caused severe respiratory disease and effectively stopped efforts to make a better one.
OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carrie B Dennis, CNM Po Box 660599, Dallas, TX 75266-0599 Ph: (214) 590-4105 | Carrie B Dennis, CNM 5201 Harry Hines Blvd, Wish Tubal Clinic, Dallas, TX 75235-7708 Ph: (214) 590-5306 |
News Archive
NicOx S.A. has announced the results of a dose-ranging phase 2 study conducted with PF‑03187207 in Japanese patients with glaucoma by its partner Pfizer Inc. PF-03187207 is a nitric oxide-donating prostaglandin analog. The study was designed to compare the safety and efficacy of several doses of PF-03187207 to Xalatan (latanoprost) and enrolled 112 Japanese patients with primary open-angle glaucoma or ocular hypertension.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD) announced today that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee recommended approval of rivaroxaban, a novel, once-daily, oral anticoagulant, for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Young women who took iron supplementation for 16 weeks significantly improved their attention, short-term and long-term memory, and their performance on cognitive tasks, even though many were not considered to be anemic when the study began, according to researchers at Pennsylvania State University.
Research led by Johns Hopkins Children's Center scientists has figured out why a respiratory syncytial virus vaccine used in 1966 to inoculate children against the infection instead caused severe respiratory disease and effectively stopped efforts to make a better one.
OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory.
› Verified 3 days ago
Ms. Valerie Joy Phillips, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3453 Saint Francis Ave, Suite 128, Dallas, TX 75228 Phone: 972-279-0559 | |
Jessica Frankfurt, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 8305 Walnut Hill Ln Ste 100, Dallas, TX 75231 Phone: 214-363-7801 | |
Waltona Cummings, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 5201 Harry Hines Blvd, Wish Tubal Clinic, Dallas, TX 75235 Phone: 214-590-5306 Fax: 214-590-2798 | |
Susan P Hovinen, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-3838 Fax: 214-645-0078 | |
Sherry Ann Burnam, C.N.M. Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 5750 Pineland Dr Ste 300a, Dallas, TX 75231 Phone: 214-221-0855 Fax: 239-343-7185 | |
Phyllis Nzeakor, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 5200 Harry Hines Blvd, Dallas, TX 75235 Phone: 214-590-8000 | |
Shannon G. Curtis, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 5201 Harry Hines Blvd, Wish Tubal Clinic, Dallas, TX 75235 Phone: 214-590-5306 Fax: 214-590-2798 |